Tamaño, participación y crecimiento del mercado de biotecnología | Análisis 2025

  • Report Code : TIPHE100001316
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 141
Buy Now

[Informe de investigación] Se estima que el tamaño del mercado de la biotecnología alcanzará los 471.336,40 millones de dólares en 2025, frente a los 218.012,10 millones de dólares de 2017; se estima que crecerá a una tasa compuesta anual del 10,5% durante 2017-2025.

Perspectivas del mercado y visión del analista:En febrero de 2021, Selvita lanzó su nueva plataforma de ensayo fenotípico basada en células para el descubrimiento de fármacos. La Plataforma se utilizará para probar nuevos compuestos con potencial terapéutico en múltiples áreas, incluidas enfermedades neuroinflamatorias y fibróticas, entre otras, abordando limitaciones específicas de los métodos terapéuticos existentes. La plataforma permitirá a Selvita complementar su cartera integrada de servicios de descubrimiento de fármacos con un método novedoso y potente para descubrir y desarrollar nuevos medicamentos de forma rápida y eficaz.
  • En diciembre de 2021, Thermo Fisher Scientific Inc. anunció que había completado la adquisición de PPD, Inc., un proveedor líder mundial de servicios de investigación clínica para la industria biofarmacéutica y biotecnológica, por 17.400 millones de dólares.

    Impacto de Covid-19:

  • La pandemia de COVID-19 ha impactado positivamente el mercado de la biotecnología. Las empresas están desarrollando nuevas opciones de tratamiento para combatir el brote de COVID-19. Por ejemplo, en diciembre de 2020, Thermo Fisher Scientific anunció la marca CE de su kit combinado TaqPath COVID-19, gripe A/B y virus respiratorio sincitial (RSV) para el diagnóstico in vitro de SARS-CoV-2, RSV A/ Infecciones B e influenza A/B.  

    Hay un aumento en los avances y oportunidades para el desarrollo de fármacos y la fabricación de vacunas para la infección por COVID-19. Por ejemplo, según la Federación Internacional de Asociaciones y Fabricantes Farmacéuticos (IFPMA), se produjeron más de 11 mil millones de dosis de la vacuna COVID-19 en todo el mundo, lo que dio como resultado el mayor programa de inmunización a nivel mundial. Además, el auge de las vacunas de ARNm y los procesos de aprobación acelerados han provocado un aumento de los ingresos relacionados con las vacunas, como lo demuestra la generación conjunta de ingresos de alrededor de 31 mil millones de dólares en 2021 de Pfizer/BioNTech y Johnson & Vacunas Johnson Moderna.  

    Panorama competitivo y empresas clave:

    Algunos de los actores destacados que operan en el mercado global de biotecnología incluyen Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Danaher, QIAGEN, Agilent Technologies, BD, Bio-Rad Laboratories, Inc. y Illumina, Inc. Estas empresas se centran en el lanzamiento de nuevos productos y expansiones geográficas para satisfacer la creciente demanda de los consumidores en todo el mundo y aumentar su gama de productos en carteras especializadas. Tienen una presencia global generalizada, lo que les permite atender a un gran conjunto de clientes y, posteriormente, aumentar su cuota de mercado.

    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is the expected CAGR growth in the forecast period?

    The biotechnology in healthcare market is projected to reach US$ 471,336.4 million by 2027; it is expected to grow at a CAGR of 10.5%

    What is the forecast period in this market report?

    The forecast period of biotechnology in healthcare market is 2017 - 2025.

    What is the key factor driving the biotechnology market?

    Key factors that are driving the growth of this market are the declining prices of genome sequencing, increasing innovative technologies, increasing number of initiatives by private and government bodies.

    What are the restraining factors for biotechnology market across the globe?

    Factors such as risks associated with genetic data and systemic risks of genetically modified crops are likely to restrain the market growth to a certain extent.

    Which segment is fastest growing?

    As per Technology based insights, the nanotechnology segment is fastest growing segment and is accounted to grow at the CAGR of 13.2%.

    Which is the largest segment among technology segment?

    The DNA sequencing is the largest segment among the technology segment in the biotechnology market in 2017 and is also anticipated to hold the largest market in the year 2025.

    The List of Companies

    1. Thermo Fisher Scientific Inc.
    2. Merck KGaA
    3. PerkinElmer, Inc.
    4. Agilent Technologies, Inc.
    5. F. Hoffmann-La Roche Ltd.
    6. Danaher
    7. QIAGEN
    8. BD
    9. Bio-Rad Laboratories, Inc.
    10. Illumina, Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports